---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-062900"
form_type: "8-K"
ticker: "MRAI"
cik: "0001844392"
company_name: "Marpai, Inc."
filed_at: "2023-11-13T23:59:59+00:00"
generated_at: "2026-06-08T05:27:38.633046+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Marpai Q3 revenue $8.7M (+77% YoY); net loss $7.3M; withdraws S-1, suspends guidance

## Summary
- Total revenue $8.7M for Q3 2023, up 77% YoY, driven by acquisition of Maestro Health.
- Net loss of $7.3M ($0.98 per share) vs. net loss $5.8M ($1.14 per share) in Q3 2022.
- Customers' employees reached ~37,000, a 126% increase from 16,000 a year ago.
- Withdrew its Form S-1 registration statement due to adverse market conditions; evaluating financing.
- Suspended full-year 2023 financial guidance; company focusing on path to profitability.

## SEC filing metadata
- accession: 0000950170-23-062900
- form_type: 8-K
- ticker: MRAI
- cik: 0001844392
- company_name: Marpai, Inc.
- filed_at: 2023-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844392/000095017023062900/0000950170-23-062900-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844392/000095017023062900/mrai-20231113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-062900
- JSON: https://secwatch.observer/filing/0000950170-23-062900.json
- Plain text: https://secwatch.observer/filing/0000950170-23-062900.txt

## Key facts
- Earnings Releases
  Marpai, Inc. reported three and nine months ended September 30, 2023 results: revenue $8.7 million, net income nearly $7.3 million, EPS ($0.98) per share.
  - Period: three and nine months ended September 30, 2023
  - Revenue: $8.7 million
  - Net income: nearly $7.3 million
  - EPS: ($0.98) per share
  - Result: reported results
  source text: Health, LLC (“Maestro Health”) since its acquisition on November 1, 2022. Third Quarter 2023 Highlights: • Total revenue for the three months ended September 30, 2023 was $8.7 million, representing an increase of $3.8 million, or nearly 77%, over the same period in 2022. The primary reason for this increase was due to the revenue from the acquisition of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1844392/000095017023062900/0000950170-23-062900-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.